BACKGROUND: Information in health administrative databases increasingly guides renal care and policy. STUDY DESIGN: Systematic review of observational studies. SETTING & POPULATION: Studies describing the validity of codes for acute kidney injury (AKI) and chronic kidney disease (CKD) in administrative databases operating in any jurisdiction. SELECTION CRITERIA: After searching 13 medical databases, we included observational studies published from database inception though June 2009 that validated renal diagnostic and procedural codes for AKI or CKD against a reference standard. INDEX TESTS: Renal diagnostic or procedural administrative data codes. REFERENCE TESTS: Patient chart review, laboratory values, or data from a high-quality patient registry. RESULTS: 25 studies of 13 databases in 4 countries were included. Validation of diagnostic and procedural codes for AKI was present in 9 studies, and validation for CKD was present in 19 studies. Sensitivity varied across studies and generally was poor (AKI median, 29%; range, 15%-81%; CKD median, 41%; range, 3%-88%). Positive predictive values often were reasonable, but results also were variable (AKI median, 67%; range, 15%-96%; CKD median, 78%; range, 29%-100%). Defining AKI and CKD by only the use of dialysis generally resulted in better code validity. The study characteristic associated with sensitivity in multivariable meta-regression was whether the reference standard used laboratory values (P < 0.001); sensitivity was 39% lower when laboratory values were used (95% CI, 23%-56%). LIMITATIONS: Missing data in primary studies limited some of the analyses that could be done. CONCLUSIONS: Administrative database analyses have utility, but must be conducted and interpreted judiciously to avoid bias arising from poor code validity.
BACKGROUND: Information in health administrative databases increasingly guides renal care and policy. STUDY DESIGN: Systematic review of observational studies. SETTING & POPULATION: Studies describing the validity of codes for acute kidney injury (AKI) and chronic kidney disease (CKD) in administrative databases operating in any jurisdiction. SELECTION CRITERIA: After searching 13 medical databases, we included observational studies published from database inception though June 2009 that validated renal diagnostic and procedural codes for AKI or CKD against a reference standard. INDEX TESTS: Renal diagnostic or procedural administrative data codes. REFERENCE TESTS: Patient chart review, laboratory values, or data from a high-quality patient registry. RESULTS: 25 studies of 13 databases in 4 countries were included. Validation of diagnostic and procedural codes for AKI was present in 9 studies, and validation for CKD was present in 19 studies. Sensitivity varied across studies and generally was poor (AKI median, 29%; range, 15%-81%; CKD median, 41%; range, 3%-88%). Positive predictive values often were reasonable, but results also were variable (AKI median, 67%; range, 15%-96%; CKD median, 78%; range, 29%-100%). Defining AKI and CKD by only the use of dialysis generally resulted in better code validity. The study characteristic associated with sensitivity in multivariable meta-regression was whether the reference standard used laboratory values (P < 0.001); sensitivity was 39% lower when laboratory values were used (95% CI, 23%-56%). LIMITATIONS: Missing data in primary studies limited some of the analyses that could be done. CONCLUSIONS: Administrative database analyses have utility, but must be conducted and interpreted judiciously to avoid bias arising from poor code validity.
Authors: Chi-Yuan Hsu; Raymond K Hsu; Kathleen D Liu; Jingrong Yang; Amanda Anderson; Jing Chen; Vernon M Chinchilli; Harold I Feldman; Amit X Garg; Lee Hamm; Jonathan Himmelfarb; James S Kaufman; John W Kusek; Chirag R Parikh; Ana C Ricardo; Sylvia E Rosas; Georges Saab; Daohang Sha; Edward D Siew; James Sondheimer; Jonathan J Taliercio; Wei Yang; Alan S Go Journal: J Am Soc Nephrol Date: 2019-06-24 Impact factor: 10.121
Authors: Richard A Hansen; Michael D Gray; Brent I Fox; Joshua C Hollingsworth; Juan Gao; Peng Zeng Journal: Drug Saf Date: 2013-10 Impact factor: 5.606
Authors: Jeremiah R Brown; Michael E Rezaee; William M Hisey; Kevin C Cox; Michael E Matheny; Mark J Sarnak Journal: Am J Nephrol Date: 2016-04-29 Impact factor: 3.754
Authors: Louisa Sukkar; Amy Kang; Carinna Hockham; Tamara Young; Min Jun; Celine Foote; Roberto Pecoits-Filho; Brendon Neuen; Kris Rogers; Carol Pollock; Alan Cass; David Sullivan; Germaine Wong; John Knight; David Peiris; Martin Gallagher; Meg Jardine Journal: Diabetes Care Date: 2020-03-11 Impact factor: 19.112
Authors: Nausheen F Siddiqui; Steven G Coca; Philip J Devereaux; Arsh K Jain; Lihua Li; Jin Luo; Chirag R Parikh; Michael Paterson; Heather Thiessen Philbrook; Ron Wald; Michael Walsh; Richard Whitlock; Amit X Garg Journal: CMAJ Date: 2012-06-25 Impact factor: 8.262
Authors: Thomas S Valley; Brahmajee K Nallamothu; Michael Heung; Theodore J Iwashyna; Colin R Cooke Journal: Crit Care Med Date: 2018-02 Impact factor: 7.598